Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print

Search Results for 'Financial Report: Alkermes'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 30, 2014
Manufacturing and royalty revenues down 24% in the quarter Read More »
By Gil Roth
Published January 6, 2014
Expects to begin trials of MS prodrug in mid-2014 Read More »
Published October 31, 2013
Revenues up 13%, loss narrows Read More »
Published July 25, 2013
Key commercial products up 22% in the quarter Read More »
Published January 31, 2013
Revenues up 8% in the quarter Read More »
Alkermes
By Fidelma Callanan, Sr. Director Marketing and Commercial Development
Four decades delivering contract pharma solutions for our Partners Alkermes Contract Pharma Services provid… Read More »
Published May 17, 2012
EDT merger boosts revenues Read More »
Haemtech Biopharma Services
By Robert Myers, Director, Business & Marketing
Haemtech Biopharma Services provides solutions for your biopharmaceutical, diagnostic or other proteinaceous product in areas of anti-drug assay development, TGA assay development, CHO host cell protein detection, and stability and release testing. W… Read More »
By Elena Chikina, Dr.
By Jaydeep Adhikari, Business Development & Licencing
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On